The British Medicines and Healthcare products Regulatory Agency (MHRA) has forbidden Swedish authorities to reveal Strattera suicide data. A release in Sweden of data about suicides and suicide attempts from Eli Lilly's Strattera is said to hurt the relations between the two countries.

A not released discussion paper from the British medical agency (MHRA) reveals 130 reports of suicidality in one month from treatment with Strattera. In addition the paper tells about 766 spontaneous reports of cardiac disorders and 172 of liver injury, and about 20 completed suicides.

The Swedish Medical Products Agency (MPA) knows that Gillberg's and Lilly's clinical trial of Strattera is a catastrophe. It has nevertheless been allowed to continue.

Campaign launched to rally Multiple Sclerosis patients in potential class action lawsuit against the manufacturer of pharmaceutical drugs Tysabri and Avonex.